Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 128-135

  Wu, Xiongyan ^a   Chen, Xuehua ^a   Zhou, Quan ^a   Li, Pu ^a   Yu, Beiqin ^a   Li, Jianfang ^a   Qu, Ying ^a   Yan, Jun ^b   Yu, Yingyan ^a   Yan, Min ^a   Zhu, Zhenggang ^a   Liu, Bingya ^a   Su, Liping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cancer associated fibroblasts; Gastric cancer; HGF

Indexed keywords

SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CARCINOGENESIS; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; STOMACH CANCER; STROMA; TUMOR STROMAL FIBROBLAST;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

EID: 84878455562     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.002     Document Type: Article

References (37)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA. Cancer. J. Clin. 2011, 61:69-90.
2. J. Ferlay, F. Bray, D. Forman, C. Mathers, D.M. Parkin, GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France, 2010. <>. http://globocan.iarc.fr.
3. Moon Y.W., Jeung H.C., Rha S.Y., Yoo N.C., Roh J.K., Noh S.H., Kim B.S., Chung H.C. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Ann. Surg. Oncol. 2007, 14:2730-2737.
4. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
5. Cirri P., Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am. J. Cancer Res. 2011, 1:482-497.
6. Mueller M.M., Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004, 4:839-849.
7. O'Brien P., O'Conner B.F. Seprase: an over-view of an important matrix serine protease. Biochim. Biophys. Acta 2008, 1784:1130-1145.
8. Sugimoto H., Mundel T.M., Kieran M.W., Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol. Ther. 2006, 5:1640-1646.
9. Finak G., Bertos N., Pepin F., Sadekova S., Souleimanova M., Zhao H., Chen H., Omeroglu G., Meterissian S., Omeroglu A., Hallett M., Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008, 14:518-527.
10. Tsujino T., Seshimo I., Yamamoto H., Ngan C.Y., Ezumi K., Takemasa I., Ikeda M., Sekimoto M., Matsuura N., Monden M. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer. Res. 2007, 13:2082-2090.
11. Cohen S.J., Alpaugh R.K., Palazzo I., Meropol N.J., Rogatko A., Xu Z., Hoffman J.P., Weiner L.M., Cheng J.D. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 2008, 37:154-158.
12. Zhi K., Shen X., Zhang H., Bi J. Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers. J. Exp. Clin. Cancer Res. 2010, 29:66.
13. Ostman A., Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr. Opin. Genet. Dev. 2009, 19:67-73.
14. Mishra P., Banerjee D., Ben-Baruch A. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J. Leukocyte Biol. 2011, 89:31-39.
15. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:239-242.
16. Trusolino L., Comoglio P.M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer 2002, 2:289-300.
17. Matsumoto K., Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer 2006, 119:477-483.
18. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4:915-925.
19. Cecchi F., Rabe D.C., Bottaro D.P. Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16:553-572.
20. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 2002, 110:341-350.
21. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007, 67:10123-10128.
22. Direkze N.C., Hodivala-Dilke K., Jeffery R., Hunt T., Poulsom R., Oukrif D., Alison M.R., Wright N.A. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004, 64:8492-8495.
23. Mishra P.J., Humeniuk R., Medina D.J., Alexe G., Mesirov J.P., Ganesan S., Glod J.W., Banerjee D. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008, 68:4331-4339.
24. Stuelten C.H., Busch J.I., Tang B., Flanders K.C., Oshima A., Sutton E., Karpova T.S., Roberts A.B., Wakefield L.M., Niederhuber J.E. Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One 2010, 5:e9832.
25. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147.
26. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
27. Shao Z.M., Nguyen M., Barsky S.H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 2000, 19:4337-4345.
28. Naber H.P., ten Dijke P., Pardali E. Role of TGF-beta in the tumor stroma. Curr. Cancer Drug Targets 2008, 8:466-472.
29. Gohda E., Matsunaga T., Kataoka H., Takebe T., Yamamoto I. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor. Cytokine 1994, 6:633-640.
30. Giannoni E., Bianchini F., Masieri L., Serni S., Torre E., Calorini L., Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 2010, 70:6945-6956.
31. Matsumoto K., Okazaki H., Nakamura T. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J. Biochem. 1995, 117:458-464.
32. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
33. Yang F., Tuxhorn J.A., Ressler S.J., McAlhany S.J., Dang T.D., Rowley D.R. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005, 65:8887-8895.
34. Augsten M., Hägglöf C., Olsson E., Stolz C., Tsagozis P., Levchenko T., Frederick M.J., Borg A., Micke P., Egevad L., Ostman A. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc. Natl. Acad. Sci. USA 2009, 106:3414-3419.
35. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA 2004, 101:4966-4971.
36. Comoglio P.M. Pathway specificity for Met signalling. Nat. Cell. Biol. 2001, 3:E161-162.
37. Wu C.W., Chi C.W., Su T.L., Liu T.Y., Lui W.Y., P'Eng F K. Serum hepatocyte growth factor level associate with gastric cancer progression. Anticancer Res. 1998, 18:3657-3659.